All tenders
75A50123C00056
ADVANCE THE DEVELOPMENT OF POTENT, CROSS-REACTIVE MULTISPECIFIC ANTIBODIES FOR THE PREP COUNTERMEASURE OF COVID-19 AND SEASONAL AND HIGHLY PATHOGENIC AVIAN INFLUENZA.
Office of Assistant Secretary for Preparedness and Response · United States
This tender closed on Tuesday, February 29, 2028. Browse open opportunities
Time Left to Bid
Closed
ClosedOtherFederal
Basic information
- Reference number
- 75A50123C00056
- Issuing organization
- Office of Assistant Secretary for Preparedness and Response · Find award history →
- Government level
- Federal
- Solicitation type
- Other
- Title
- ADVANCE THE DEVELOPMENT OF POTENT, CROSS-REACTIVE MULTISPECIFIC ANTIBODIES FOR THE PREP COUNTERMEASURE OF COVID-19 AND SEASONAL AND HIGHLY PATHOGENIC AVIAN INFLUENZA.
- Source
- USASpending (Federal)
- Source ID
- usa-75A50123C00056
Details
- Location
- United States
Description
ADVANCE THE DEVELOPMENT OF POTENT, CROSS-REACTIVE MULTISPECIFIC ANTIBODIES FOR THE PREP COUNTERMEASURE OF COVID-19 AND SEASONAL AND HIGHLY PATHOGENIC AVIAN INFLUENZA. Awarded to: MODEX THERAPEUTICS, INC Agency: Department of Health and Human Services Sub-agency: Office of Assistant Secretary for Preparedness and Response Award type: DEFINITIVE CONTRACT
Dates
- Publication
- 2023/09/27 12:00:00 AM UTC
- Closing date
- 2028/02/29 12:00:00 AM UTC
Estimated value
$103.5M USD
Classification
Normalized category
Other